ActoGeniX
A biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs.
loading funding rounds…
Ventech(exited)
Gimv(exited)
Baekeland Funds(exited)
Biotech Fund Flanders(exited)
VIB(exited)
Aescap(exited)
EQT Life Sciences(exited)
Ghent University(exited)
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 92 % | (54 %) | 31 % | 14 % | (46 %) | 41 % | (27 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 58 % | (25 %) | (21 %) | (21 %) | (16 %) | 11 % | 2 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 56 % | (41 %) | (26 %) | (21 %) | (38 %) | 11 % | 13 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads